← FDA Drug Approvals (Drugs@FDA)
BRINZOLAMIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PADAGIS US · Approved 2023-07-28
Drug application
- FDA Application #
ANDA211914- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- BRINZOLAMIDE
- Generic name
- BRINZOLAMIDE
- Active ingredients
- BRINZOLAMIDE
- Dosage form
- SUSPENSION/DROPS
- Route
- OPHTHALMIC
- Marketing status
- Discontinued
- Sponsor
- PADAGIS US
- Manufacturer
- Padagis US LLC
- First approval
- 2023-07-28
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown